...
首页> 外文期刊>Synapse >Fenfluramine-Induced Serotonin Release Decreases [11C]AZ10419369 Binding to 5-HT1B-Receptors in the Primate Brain
【24h】

Fenfluramine-Induced Serotonin Release Decreases [11C]AZ10419369 Binding to 5-HT1B-Receptors in the Primate Brain

机译:芬氟拉明诱导的5-羟色胺释放降低[11C] AZ10419369与灵长类动物脑中5-HT1B受体的结合。

获取原文
获取原文并翻译 | 示例
           

摘要

The need for positron emission tomography (PET)-radioligands that are sensitive to changes in endogenous serotonin (5-HT) levels in brain is recognized in experimental and clinical psychiatric research. We recently developed the novel PET radioligand [11C]AZ10419369 that is highly selective for the 5-HT1B receptor. In this PET-study in three cynomolgus monkeys, we examined the sensitivity of [11C]AZ10419369 to altered endogenous 5-HT levels. Fenfluramine-induced 5-HT release decreased radioligand binding in a dose-dependent fashion with a regional average of 27% after 1 mg/kg and 50% after 5 mg/kg. This preliminary study supports that [11C]AZ10419369 is sensitive to endogenous 5-HT levels in vivo and may serve as a tool to examine the pathophysiology and treatment of major psychiatric disorders.
机译:实验和临床精神病学研究认识到需要对大脑中内源性血清素(5-HT)水平变化敏感的正电子发射断层扫描(PET)-放射配体。我们最近开发了对5-HT1B受体具有高度选择性的新型PET放射性配体[11C] AZ10419369。在这项对3只食蟹猴的PET研究中,我们研究了[11C] AZ10419369对改变的内源性5-HT水平的敏感性。芬氟拉明诱导的5-HT释放以剂量依赖的方式降低了放射性配体的结合,区域平均值为1 mg / kg后为27%,5 mg / kg后为50%。这项初步研究支持[11C] AZ10419369对体内内源性5-HT水平敏感,并可作为检查主要精神疾病的病理生理学和治疗的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号